IP Library Patent Application 17780819
Patent Application
App. No. 17/780,819

METHODS AND COMPOSITIONS FOR CULTURING HEMOGLOBIN-DEPENDENT BACTERIA

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/780,819
Abstract

Provided herein are compositions and methods related to culturing bacteria (such as hemoglobin-dependent bacteria) with a heme-containing polypeptide (such as a heme-containing polypeptide that is not sourced from an animal and/or can be recombinantly produced).

Claims (60)

1 . A method of culturing hemoglobin-dependent bacteria, the method comprising incubating the hemoglobin-dependent bacteria in a growth medium that comprises a heme-containing polypeptide, wherein the heme-containing polypeptide is:

(i) a piscine polypeptide;

(ii) an avian polypeptide; or

(iii) a non-animal-derived polypeptide.

2 . The method of claim 1 , wherein the heme-containing polypeptide is a hemoglobin.

3 . (canceled)

4 . The method of claim 1 , wherein the heme-containing polypeptide is a leghemoglobin.

5 . The method of claim 1 , wherein the heme-containing polypeptide is a myoglobin.

6 . The method of claim 1 , wherein the heme-containing polypeptide is a piscine polypeptide.

7 - 8 . (canceled)

9 . The method of claim 1 , wherein the heme-containing polypeptide is an avian polypeptide.

10 - 11 . (canceled)

12 . The method of claim 1 , wherein the non-animal-derived polypeptide is purified from a plant, bacteria, cyanobacteria, fungus, algae, grain, legume, and/or protozoa.

13 - 18 . (canceled)

19 . The method of claim 1 , wherein the heme-containing polypeptide comprises an amino acid sequence with at least 70% identity to an amino acid sequence in any one of SEQ ID NOs: 1-29, 31, 33, 35, 37, 39, 41, 43, 114, or a combination thereof.

20 . (canceled)

21 . The method of claim 1 , wherein the heme-containing polypeptide comprises an amino acid sequence with at least 70% identity to the amino acid sequence of SEQ ID NO: 4.

22 - 23 . (canceled)

24 . The method of claim 1 , wherein the heme-containing polypeptide comprises an amino acid sequence with at least 70% identity to the amino acid sequence of SEQ ID NO: 114 or UniProtKB—P02236 (LGB2_SOYBN).

25 - 33 . (canceled)

34 . The method of claim 12 , wherein the heme-containing polypeptide is a soy leghemoglobin recombinantly expressed in Pichia pastoris.

35 . The method of claim 1 , wherein the hemoglobin-dependent bacteria are bacteria of the genus Actinomyces, Alistipes, Anaerobutyricum, Bacillus, Bacteroides, Cloacibacillus, Clostridium, Collinsella, Cutibacterium, Eisenbergiella, Erysipelotrichaceae, Eubacterium/Mogibacterium, Faecalibacterium, Fournierella, Fusobacterium, Megasphaera, Parabacteroides, Peptoniphilus, Peptostreptococcus, Porphyromonas, Prevotella, Propionibacterium, Rarimicrobium, Shuttleworthia, Turicibacter , or Veillonella.

36 . The method of claim 1 , wherein the hemoglobin-dependent bacteria are of the genus Prevotella.

37 - 38 . (canceled)

39 . The method of claim 36 , wherein the Prevotella comprise at least 99% genomic, 16S and/or CRISPR sequence identity to the nucleotide sequence of the Prevotella Strain B 50329 (NRRL accession number B 50329).

40 . (canceled)

41 . The method of claim 36 , wherein the Prevotella comprise at least 99% genomic, 16S and/or CRISPR sequence identity to the nucleotide sequence of the Prevotella Strain C (PTA-126140).

42 . (canceled)

43 . The method of claim 36 , wherein the hemoglobin-dependent bacteria are a strain of Prevotella bacteria comprising one or more proteins listed in Table 1.

44 . The method of claim 36 , wherein the hemoglobin-dependent bacteria are from a strain of Prevotella substantially free of a protein listed in Table 2.

45 - 48 . (canceled)

49 . A method of culturing hemoglobin-dependent bacteria, the method comprising (a) adding a heme-containing polypeptide and hemoglobin-dependent bacteria to a growth medium; and (b) incubating the hemoglobin-dependent bacteria in the growth medium, wherein the heme-containing polypeptide is:

(i) a piscine polypeptide;

(ii) an avian polypeptide; or

(iii) a non-animal-derived polypeptide.

50 . A bioreactor comprising hemoglobin-dependent bacteria in a growth medium comprising a heme-containing polypeptide, wherein the heme-containing polypeptide is:

(i) a piscine polypeptide;

(ii) an avian polypeptide; or

(iii) a non-animal-derived polypeptide.

51 - 52 . (canceled)

53 . A composition comprising

a) hemoglobin-dependent bacteria, and

b) a growth medium comprising a heme-containing polypeptide, wherein the heme-containing polypeptide is:

(i) a piscine polypeptide;

(ii) an avian polypeptide; or

(iii) a non-animal-derived polypeptide.

54 . A growth medium for use in culturing hemoglobin-dependent bacteria, the growth medium comprising a heme-containing polypeptide, wherein the heme-containing polypeptide is:

(i) a piscine polypeptide;

(ii) an avian polypeptide; or

(iii) a non-animal-derived polypeptide.

55 . A heme-containing polypeptide for use as a supplement in a growth medium for facilitating the growth of hemoglobin-dependent bacteria, wherein the heme-containing polypeptide is:

(i) a piscine polypeptide;

(ii) an avian polypeptide; or

(iii) a non-animal-derived polypeptide.

56 . A bacterial composition comprising

(a) hemoglobin-dependent bacteria, and

(b) a heme-containing polypeptide, wherein the heme-containing polypeptide is:

(i) a piscine polypeptide;

(ii) an avian polypeptide; or

(iii) a non-animal-derived polypeptide.

Assignments (2)
SECURITY INTEREST Recorded Jul 14, 2023
From: EVELO BIOSCIENCES, INC.
To: HORIZON TECHNOLOGY FINANCE CORPORATION
Reel/Frame 064274/0354 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2022
From: KRAVITZ, VALERIA; RAY, MANAS; SIZOVA, MARIA
To: EVELO BIOSCIENCES, INC.
Reel/Frame 061924/0388 →